﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>SelectScience.net Feed</title><description>All the latest from the world of laboratory science from SelectScience.net</description><link>http://www.selectscience.net/RSS.aspx</link><copyright>(c) 2012, SelectScience Ltd. All rights reserved.</copyright><item><title>Generics, Supergenerics and Patent Strategies</title><link>http://selectscience.net/go/?partnerID=33&amp;itemID=3867&amp;itemTypeID=1</link><description>SMi's is pleased to announce its Generics, Supergenerics and Patent Strategy conference that will provide you with an excellent overview of the industry and where it stands at the moment along with case studies from the big players in the market showing how they have handled issues and how they see the industry moving forward. We will also be covering some of the current regulatory issues and also the big Pharma perspective of their movements in the generic field. &lt;BR&gt;&lt;BR&gt;&lt;STRONG&gt;Attend this con</description><pubDate>Fri, 03 Feb 2012 11:53:32 GMT</pubDate><dc:creator>SMi Group Ltd</dc:creator></item><item><title>ADC Summit</title><link>http://selectscience.net/go/?partnerID=33&amp;itemID=3866&amp;itemTypeID=1</link><description>SMi is proud to present their inaugural ADC Summit. This new and exciting event will present attendees with an in-depth view into novel innovations, developments and utilities of antibody-drug conjugates. The 2012 speaker line up, with key experts from all sectors of the industry will provide attendees with a unique insight into latest technological and scientific developments and will be the perfect platform for debate and problem-solving discussion. &lt;BR&gt;&lt;BR&gt;&lt;STRONG&gt;Key benefits of attending:&lt;/</description><pubDate>Fri, 03 Feb 2012 11:51:12 GMT</pubDate><dc:creator>SMi Group Ltd</dc:creator></item><item><title>Biomarker Summit</title><link>http://selectscience.net/go/?partnerID=33&amp;itemID=3865&amp;itemTypeID=1</link><description>GTC is proud to present the Biomarker Summit 2012, to be held March 15-16 in San Diego, California. Assembling leading scientists, researchers, decision-makers and other players across the industry spectrum, the Summit provides a unique opportunity to gain the latest biomarker developments in diagnostics, oncology and the business of biomarkers. &lt;BR&gt;&lt;BR&gt;The Summit’s four tracks allows attendees to engage in individual programs – or portions of all tracks – while enjoying networking opportunities</description><pubDate>Fri, 03 Feb 2012 11:39:46 GMT</pubDate><dc:creator>GTCbio</dc:creator></item><item><title>Targets and Strategies in Drug Discovery Summit</title><link>http://selectscience.net/go/?partnerID=33&amp;itemID=3864&amp;itemTypeID=1</link><description>The Targets and Strategies in Drug Discovery Summit brings together experts from academia and industry to discuss the emerging targets, therapeutics and strategies against cancer, showcase ubiquitins' huge potential in the development of therapeutics and display novel discovery in developing ocular disease therapies. Attendees will also receive updates on government policy, recent regulations, important investments and partnering strategies. The summit takes place in Las Vegas, NV on February 27</description><pubDate>Fri, 03 Feb 2012 11:29:47 GMT</pubDate><dc:creator>GTCbio</dc:creator></item><item><title>HIT '12: Healthcare Information Transformation</title><link>http://selectscience.net/go/?partnerID=33&amp;itemID=3863&amp;itemTypeID=1</link><description>Today's dynamic IT healthcare professionals face unprecedented opportunities for providing new and improved services in support of increasing efficiencies, improving patient care, and decreasing cost. However, with these opportunities come challenges: ensuring security and privacy, complying with the numerous regulations and "meaningful use" guidelines. Looming deadlines and various projects are competing for IT's time. The HIT '12: Healthcare Information Transformation Conference will help you </description><pubDate>Fri, 03 Feb 2012 10:31:39 GMT</pubDate><dc:creator>Opal Events</dc:creator></item><item><title>Analysis of Drug Substances in Headache Medicines with the PerkinElmer Flexar FX-15 System Equipped with a PDA Detector</title><link>http://selectscience.net/go/?partnerID=33&amp;itemID=24022&amp;itemTypeID=10</link><description>This application note presents a modified USP method for the analysis of aspirin, acetaminophen and caffeine using a superficially porous particle column and a PerkinElmer® UHPLC platform. The changes to the USP method increase throughput and reduce solvent consumption. Method conditions and performance are presented. Two headache medicines, one brand name and one generic are tested and the amount of the active ingredients determined.</description><pubDate>Fri, 03 Feb 2012 00:00:00 GMT</pubDate><dc:creator>PerkinElmer, Inc.  - published by SelectScience.net</dc:creator></item><item><title>Bio-Rad Introduces New Mini-PROTEAN® TGX Stain-Free™ Precast Gels</title><link>http://selectscience.net/go/?partnerID=33&amp;itemID=24227&amp;itemTypeID=10</link><description>Bio-Rad Laboratories, Inc. announced today that it has launched its Mini-PROTEAN TGX (Tris-Glycine eXtended) Stain-Free precast gels, providing researchers with the fastest separation and imaging capabilities available for Laemmli PAGE. The gels include a unique trihalo compound that allows rapid fluorescent detection of proteins in gels or on membranes without the need for staining.</description><pubDate>Fri, 03 Feb 2012 00:00:00 GMT</pubDate><dc:creator>Bio-Rad Laboratories, Inc. - published by SelectScience.net</dc:creator></item><item><title>Measuring Glycolysis and Oxidative Metabolism in Cancer Cells</title><link>http://selectscience.net/go/?partnerID=33&amp;itemID=24212&amp;itemTypeID=10</link><description>Learn more about a method for validated OCR and ECAR as indicators of cellular respiration and glycolysis respectively in this application note. By measuring their responses to three well-defined modulators of mitochondrial respiration and glycolysis in the A549 human cancer cell line, it was reported that 2-4 DNP uncouples respiration from ATP synthesis, stimulating both respiration and glycolysis. 2-DG inhibits hexokinase, the first enzyme required for glycolysis, specifically inhibi</description><pubDate>Fri, 03 Feb 2012 00:00:00 GMT</pubDate><dc:creator>Seahorse Bioscience - published by SelectScience.net</dc:creator></item><item><title>Metabolic Pathway Determination Using the XF24 Analyzer</title><link>http://selectscience.net/go/?partnerID=33&amp;itemID=24211&amp;itemTypeID=10</link><description>The XF24 Analyzer non-invasively measures physiological changes in cellular bioenergetics and metabolic pathways in vitro using optical biosensors in a 24-well format. Shifts between mitochondrial respiration and glycolysis as a result of genetic, pharmacologic or environmental manipulation can be measured in a single assay the method of which is described in this application note. XF24 assays provide increased throughput in a drug discovery format.&lt;BR&gt;</description><pubDate>Fri, 03 Feb 2012 00:00:00 GMT</pubDate><dc:creator>Seahorse Bioscience - published by SelectScience.net</dc:creator></item><item><title>Monitoring Cure Characteristics of a Thermoset Epoxy by ATR/FTIR</title><link>http://selectscience.net/go/?partnerID=33&amp;itemID=24228&amp;itemTypeID=10</link><description>A high temperature epoxy curing study is presented as an example application where a high performance, robust ATR accessory is desirable. Through FTIR data, reaction kinetics was determined for demanding and high temperature applications.</description><pubDate>Fri, 03 Feb 2012 00:00:00 GMT</pubDate><dc:creator>PIKE Technologies - published by SelectScience.net</dc:creator></item><item><title>Predictive Assays for High Throughput Assessment of Cardiac Toxicity and Drug Safety</title><link>http://selectscience.net/go/?partnerID=33&amp;itemID=24194&amp;itemTypeID=10</link><description>In this poster a method is demonstrated for measuring the impact of pharmacological compounds on beating stem-cell derived human cardiomyocytes using the ImageXpress® Micro and the FLIPR® Tetra systems from Molecular Devices, LLC. Both methods allow monitoring of drug impact on the beat rate and amplitude in 96 or 384 well formats. The method demonstrated use of both systems for two important applications: screening compounds for cardiac toxicity, and pre-clinical testing of</description><pubDate>Fri, 03 Feb 2012 00:00:00 GMT</pubDate><dc:creator>Molecular Devices - published by SelectScience.net</dc:creator></item><item><title>Research Automation Solutions by Beckman Coulter Featured at SLAS 2012</title><link>http://selectscience.net/go/?partnerID=33&amp;itemID=24234&amp;itemTypeID=10</link><description>Beckman Coulter Life Sciences will offer an array of innovative platforms for cellular and molecular biology research to attendees at this year’s inaugural Society for Laboratory Automation and Screening (SLAS) conference and exhibition at the San Diego Convention Center. An extensive exhibit in booth 619 and detailed workshops will feature automated solutions for high-throughput applications in flow cytometry and the preparation of genomic samples for sequencing.</description><pubDate>Fri, 03 Feb 2012 00:00:00 GMT</pubDate><dc:creator>Beckman Coulter - published by SelectScience.net</dc:creator></item><item><title>SeraCare Launches New Infectious Disease Panels for Clinical Diagnostic Use</title><link>http://selectscience.net/go/?partnerID=33&amp;itemID=24226&amp;itemTypeID=10</link><description>SeraCare Life Sciences has announced the launch of five new infectious disease panels for parvovirus B19, HIV, HBV, HAV and CMV markers. The panels are available for use in hospitals and clinical reference laboratories:</description><pubDate>Fri, 03 Feb 2012 00:00:00 GMT</pubDate><dc:creator>SeraCare Life Sciences - published by SelectScience.net</dc:creator></item><item><title>Do you Trust Your Laboratory's Liquid Handler?</title><link>http://selectscience.net/go/?partnerID=33&amp;itemID=24216&amp;itemTypeID=10</link><description>Pipette calibration and verification of automated liquid handlers can be one of the most laborious and tedious jobs in the routine laboratory. Some labs still pipette water onto ancient scales as a way of checking their pipettes (trust me I was doing it myself only a few years ago).</description><pubDate>Thu, 02 Feb 2012 00:00:00 GMT</pubDate><dc:creator>ARTEL - published by SelectScience.net</dc:creator></item><item><title>Roche Announces FDA Clearance for Chlamydia and Gonorrhea Test</title><link>http://selectscience.net/go/?partnerID=33&amp;itemID=24217&amp;itemTypeID=10</link><description>Roche announced yesterday that the U.S. Food and Drug Administration (FDA) has provided 510(k) clearance to the cobas&lt;SUP&gt;® &lt;/SUP&gt;CT/NG Test for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhea (NG) infections. The test is designed for use on the cobas 4800 System.</description><pubDate>Thu, 02 Feb 2012 00:00:00 GMT</pubDate><dc:creator>Cobas - Roche - published by SelectScience.net</dc:creator></item><item><title>3rd Improving Immunohistochemistry Discussion Forum</title><link>http://selectscience.net/go/?partnerID=33&amp;itemID=3862&amp;itemTypeID=1</link><description>This discussion forum focuses on the technique of immunohistochemistry, from DAB to double staining. The invited experts will be giving&amp;nbsp;short overview presentations on their sub-topics, with the majority of the day dedicated to informal question and answer troubleshooting sessions. This event has CPD accreditation &lt;BR&gt;&lt;BR&gt;On registration please submit your questions to the panel that will be asked by the chair on the day of the event.&lt;BR&gt;&lt;BR&gt;Get 10% off the registration fee by using the cod</description><pubDate>Wed, 01 Feb 2012 14:04:57 GMT</pubDate><dc:creator>EuroSciCon</dc:creator></item><item><title>Multidisciplinary Integrated Approaches to Understand Evasion of Host Immune Responses by Pathogens</title><link>http://selectscience.net/go/?partnerID=33&amp;itemID=3861&amp;itemTypeID=1</link><description>Infectious disease are still a major cause of morbidity an mortality worldwide. Successful treatment and prevention are still hampered by insufficient understanding of the subtle interactions that govern the infectious processes. &lt;BR&gt;
&lt;P&gt;Evasion of the natural or vaccine-induced immune response is often at the basis of the onset and escalation of disease and can also result in the persistence of the pathogen in chronic infections. This EuroSciCon meeting will be a premier forum for the presenta</description><pubDate>Wed, 01 Feb 2012 13:58:07 GMT</pubDate><dc:creator>EuroSciCon</dc:creator></item><item><title>Histopathology Event: Advances in research and techniques</title><link>http://selectscience.net/go/?partnerID=33&amp;itemID=3860&amp;itemTypeID=1</link><description>Chair: Dr Will Howat, Cambridge Research Institute, Cancer Research UK&amp;nbsp; &lt;BR&gt;
&lt;P&gt;This is the 9th Annual event (originally called Improving Immunohistochemistry) and is the flagship meeting for Euroscicon. Held in the centre of London this meeting draws together international experts to discuss the need for technical-based updates in the areas of immunohistochemistry, clinical and research based histopathology and in situ hybridisation. This meeting gathers together workings from clinical, a</description><pubDate>Wed, 01 Feb 2012 13:48:49 GMT</pubDate><dc:creator>EuroSciCon</dc:creator></item><item><title>17th Congress of the European Hematology Association</title><link>http://selectscience.net/go/?partnerID=33&amp;itemID=3859&amp;itemTypeID=1</link><description>The education program of EHA is as strong as ever and the Congress also includes Hematology-in-Focus, Meet-the-Expert sessions, Lunch Debates and the EHA Scientific Working Groups. Two more recent developments, the Laboratory Hematology Workshop and the Molecular Hemopoiesis Workshop have proved very popular and will continue at the 17th Congress. Lastly there will be two further innovations: a Saturday session specifically for hematology trainees and the incorporation into the Hematology-in-Foc</description><pubDate>Wed, 01 Feb 2012 13:23:27 GMT</pubDate><dc:creator>EuroCongress</dc:creator></item><item><title>Focus 2012 - Association for Clinical Biochemistry National Meeting</title><link>http://selectscience.net/go/?partnerID=33&amp;itemID=3858&amp;itemTypeID=1</link><description>Topics :&lt;BR&gt;&lt;BR&gt;•Bone Disease &amp; Calcium Metabolism &lt;BR&gt;•Cardiovascular &lt;BR&gt;•Diabetes &lt;BR&gt;•Endocrinology &lt;BR&gt;•Gut, Nutrition, Trace Elements &lt;BR&gt;•Paediatrics and IEM &lt;BR&gt;•Renal disease &lt;BR&gt;•Proteins/Enzymes &lt;BR&gt;•Lipids &lt;BR&gt;•Toxicology/TDM &lt;BR&gt;•Oncology &lt;BR&gt;•Methods, Instrumentation &lt;BR&gt;•Point of Care Testing &lt;BR&gt;•Quality Assurance &lt;BR&gt;•Molecular Genetics &lt;BR&gt;•Immunology &lt;BR&gt;•Management &lt;BR&gt;•Case Histories &lt;BR&gt;•Miscellaneous &lt;BR&gt;•Haematology &lt;BR&gt;•Microbiology &lt;BR&gt;•Brain/CNS Biochemistry &lt;BR&gt;•Clini</description><pubDate>Wed, 01 Feb 2012 12:50:57 GMT</pubDate><dc:creator>Meeting Makers</dc:creator></item></channel></rss>
